Your browser doesn't support javascript.
loading
In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials.
Gul, Seref; Ozcan, Onur; Asar, Sinan; Okyar, Alper; Baris, Ibrahim; Kavakli, Ibrahim Halil.
Affiliation
  • Gul S; Department of Chemical and Biological Engineering, Koc University, Istanbul, Turkey.
  • Ozcan O; Department of Molecular Biology and Genetics, Koc University, Istanbul, Turkey.
  • Asar S; Department of Anesthesiology and Reanimation, Bakirköy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Okyar A; Department of Pharmacology, Istanbul University Faculty of Pharmacy, Istanbul, Turkey.
  • Baris I; Department of Molecular Biology and Genetics, Koc University, Istanbul, Turkey.
  • Kavakli IH; Department of Chemical and Biological Engineering, Koc University, Istanbul, Turkey.
J Biomol Struct Dyn ; 39(17): 6772-6791, 2021 Oct.
Article in En | MEDLINE | ID: mdl-32752938
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / COVID-19 Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Biomol Struct Dyn Year: 2021 Document type: Article Affiliation country: Turkey Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / COVID-19 Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Biomol Struct Dyn Year: 2021 Document type: Article Affiliation country: Turkey Country of publication: United kingdom